Compound Q&A
What is the market or research trend for sparsentan (CAS: 254740-64-2)?
Answer
The market for sparsentan (CAS: 254740-64-2) is growing due to its potential in treating hypertension and kidney disease. Research trends are focusing on its efficacy and safety, as well as exploring its use in combination therapies. Additionally, there is increasing interest in its development for other therapeutic areas, driven by clinical trial results and positive market responses.
About
CAS No
254740-64-2
English Name
Sparsentan
Molecular Formula
C32H40N4O5S
Molecular Weight
592.76 g/mol
SMILES
CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC(=C(C=C3)C4=CC=CC=C4S(=O)(=O)NC5=NOC(=C5C)C)COCC
InChIKey
WRFHGDPIDHPWIQ-UHFFFAOYSA-N
Last Updated: 2025-10-20 19:48
